About: Antithrombotic therapy after mitral valve repair: VKA or aspirin?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antithrombotic therapy after mitral valve repair: VKA or aspirin? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2018 (uk) im November 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2018 (ast) scientific article published on 01 November 2018 (en)
publication date	wds:Q57130322-E16DBA3B-7BA2-4BA5-A10B-BBC48027381F
publication date	2018-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57130322-0772EE00-DBB8-4C9B-877F-178670DF7A53
language of work or name	English
cites work	wds:Q57130322-02636EBB-A93E-4751-9A2F-8435FE6F9149 wds:Q57130322-0F7628E2-8AEE-40DE-BABC-A35701706A80 wds:Q57130322-21D73FDF-BB2A-4EA9-8F6A-2D5C7C597A7A wds:Q57130322-314542BF-5EDD-45D4-94A3-47FB00AF7E35 wds:Q57130322-345D775B-3CE5-49DD-A39B-0924D6D665F8 wds:Q57130322-405E5731-332A-4E81-952A-8E0DA8926147 wds:Q57130322-5403CF9E-CC11-439F-B002-7383942FBAB4 wds:Q57130322-56F30A88-66DF-41FF-A7BE-A93EFEFF84B9 wds:Q57130322-5A1CD4F7-CE00-4009-991B-FCBD33C99796 wds:Q57130322-5DA12E9F-50C1-4B0C-BF77-BA9AAE0C7D46 wds:Q57130322-5FA1C928-0441-4B78-A625-D398E6CF1314 wds:Q57130322-64AFEA14-473E-4AF3-BDC0-EBD24575768F wds:Q57130322-79286072-52DB-4CC2-ABFE-07DFAC4AD2D6 wds:Q57130322-8A9B6314-904A-483F-863A-52C6C337BDF9 wds:Q57130322-957627CA-92AB-4978-8AB4-B98F4F684349 wds:Q57130322-9DB00E6B-DF23-4627-A882-EFDFF0A58FE5 wds:Q57130322-A199D3F3-2377-4370-827B-7678FEC7E47C wds:Q57130322-AF33EC5F-969C-46B8-8FAE-CD5B50683000 wds:Q57130322-BBA24130-71AE-46BF-BB80-74370496E360 wds:Q57130322-BE6A261E-2B4E-461B-A574-043AEBCBCF16 wds:Q57130322-C4A985DF-2F2B-4E63-BC47-AD76BBFEE192 wds:Q57130322-CD2AE6A8-27B8-48A8-A035-3A8693F55899 wds:Q57130322-DE69A03C-62C6-4EDE-B94B-1D5FCFBE56A0 wds:Q57130322-E08F209A-87BB-47C5-8349-9F437D33B5A1 wds:Q57130322-E23F36BA-027A-4E33-876D-41ADDCDB6B1A
cites work	Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Valve repair with Carpentier techniques. The second decade Guidelines for reporting mortality and morbidity after cardiac valve interventions☆ Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery Outcome of mitral valve repair or replacement: a comparison by propensity score analysis. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis Thromboembolic events early after mitral valve repair: incidence and predictive factors Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair Atrial Fibrillation After Surgical Correction of Mitral Regurgitation in Sinus Rhythm An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair Postoperative warfarin following mitral valve repair or bioprosthetic valve replacement Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted? Atrial fibrillation at discharge from the hospital in patients undergoing mitral valve repair
author name string	wds:Q57130322-19028A1C-7BDD-4EA7-A761-B2B6D16C71F2 wds:Q57130322-4A7A0E09-DA28-4274-BA61-22EA710938DB wds:Q57130322-5B1AAC62-DACD-46CF-AA45-870709492275 wds:Q57130322-6202276F-5CB6-41A5-851D-093EC610B05A wds:Q57130322-6788D32E-F6B8-4686-AC7A-CFFB30570083 wds:Q57130322-BB869E23-122E-47F6-B1B0-DD095B3D7FB6 wds:Q57130322-DA7F6217-8520-4BCF-9BC9-5BA1EFAFAF8F wds:Q57130322-FBD0FCBD-A749-4856-ABF8-CC492366B145 wds:Q57130322-FCB19E26-33BF-4ABA-84BC-47143871BE79
author name string	Menno V Huisman Robert J M Klautz Evert K Jansen Alexander B A Vonk Peyman Sardari Nia Anton Tomsic Samuel Heuts Jules R Olsthoorn Sake J van der Wall
rdfs:label	Antithrombotic therapy after mitral valve repair: VKA or aspirin? (en) Antithrombotic therapy after mitral valve repair: VKA or aspirin? (nl)
skos:prefLabel	Antithrombotic therapy after mitral valve repair: VKA or aspirin? (en) Antithrombotic therapy after mitral valve repair: VKA or aspirin? (nl)
name	Antithrombotic therapy after mitral valve repair: VKA or aspirin? (en) Antithrombotic therapy after mitral valve repair: VKA or aspirin? (nl)
author	wds:Q57130322-7624A4E3-FAB0-456B-97AF-05D24361136E
author	Frederikus A Klok
title	wds:Q57130322-5B253C28-2D69-469E-BEF0-B66960EBCF6A
title	Antithrombotic therapy after mitral valve repair: VKA or aspirin? (en)
page(s)	wds:Q57130322-705A130B-1A72-4740-8D07-30C8FD6729ED
page(s)	473-481
instance of	wds:Q57130322-8B3A1051-2A42-46DA-B41A-19B2ACD2FD45
instance of	scholarly article
main subject	wds:Q57130322-BE135517-0A61-4F49-83FD-C3F46FC2D6A8
main subject	aspirin
PubMed ID	wds:Q57130322-893A09D1-9484-47C3-8005-F9A1F2128CA3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30132244
PubMed ID	30132244
published in	wds:Q57130322-9B76267B-A910-4AAF-961B-6D0A25CDF697
published in	Journal of Thrombosis and Thrombolysis
issue	wds:Q57130322-3E579F71-21E3-455A-98C4-0F7E774CC904

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software